Treatment Outcomes of Unruptured Arteriovenous Malformations With a Subgroup Analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients

医学 动静脉畸形 外科 临床试验 颅内动静脉畸形
作者
John D. Nerva,Alessandra Madia Mantovani,Jason Barber,Louis J. Kim,Jason K. Rockhill,Danial K. Hallam,Basavaraj Ghodke,Laligam N. Sekhar
出处
期刊:Neurosurgery [Oxford University Press]
卷期号:76 (5): 563-570 被引量:77
标识
DOI:10.1227/neu.0000000000000663
摘要

BACKGROUND: The design and conclusions of A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) trial are controversial, and its structure limits analysis of patients who could potentially benefit from treatment. OBJECTIVE: To analyze the results of a consecutive series of patients with unruptured brain arteriovenous malformations (BAVMs), including a subgroup analysis of ARUBA-eligible patients. METHODS: One hundred five patients with unruptured BAVMs were treated over an 8-year period. From this series, 90 adult patients and a subgroup of 61 patients determined to be ARUBA eligible were retrospectively reviewed. A subgroup analysis for Spetzler-Martin grades I/II, III, and IV/V was performed. The modified Rankin Scale was used to assess functional outcome. RESULTS: Persistent deficits, modified Rankin Scale score deterioration, and impaired functional outcome occurred less frequently in ARUBA-eligible grade I/II patients compared with grade III to V patients combined (P = .04, P = .04, P = .03, respectively). Twenty-two of 39 patients (56%) unruptured grade I and II BAVMs were treated with surgery without and with preoperative embolization, and all had a modified Rankin Scale score of 0 to 1 at the last follow-up. All patients treated with surgery without and with preoperative embolization had radiographic cure at the last follow-up. CONCLUSION: The results of ARUBA-eligible and unruptured grade I/II patients overall show that excellent outcomes can be obtained in this subgroup of patients, especially with surgical management. Functional outcomes for ARUBA-eligible patients were similar to those of patients who were randomized to medical management in ARUBA. On the basis of these data, in appropriately selected patients, we recommend treatment for low-grade BAVMs. ABBREVIATIONS: ARUBA, A Randomized Trial of Unruptured Brain Arteriovenous Malformations BAVM, brain arteriovenous malformation mRS, modified Rankin Scale SAIVMs, Scottish Audit of Intracranial Vascular Malformations
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HEIKU应助香蕉君达采纳,获得10
刚刚
李健的粉丝团团长应助111采纳,获得10
1秒前
2秒前
郑万恶完成签到 ,获得积分10
2秒前
帅小鱼发布了新的文献求助20
3秒前
芽芽配茄子完成签到,获得积分10
4秒前
嘎嘎发布了新的文献求助30
4秒前
2425完成签到,获得积分10
4秒前
5秒前
9秒前
Yu发布了新的文献求助10
11秒前
研友_VZG7GZ应助平淡小凝采纳,获得10
12秒前
新世界的蜗牛完成签到,获得积分10
13秒前
RED发布了新的文献求助10
14秒前
白戎完成签到,获得积分10
16秒前
17秒前
Pitter完成签到,获得积分10
17秒前
情怀应助xgx984采纳,获得10
17秒前
狄百招完成签到,获得积分10
18秒前
酷波er应助炙热甜瓜采纳,获得10
18秒前
泥巴象完成签到 ,获得积分20
19秒前
20秒前
自信的冬日完成签到 ,获得积分10
22秒前
23秒前
CaoRouLi完成签到,获得积分10
24秒前
25秒前
27秒前
29秒前
斯文败类应助飘逸锦程采纳,获得10
29秒前
30秒前
30秒前
平淡小凝发布了新的文献求助10
31秒前
炙热甜瓜发布了新的文献求助10
32秒前
领导范儿应助陈爱佳采纳,获得10
33秒前
34秒前
苯二氮卓发布了新的文献求助10
36秒前
郦稀发布了新的文献求助10
37秒前
隐形曼青应助科研通管家采纳,获得10
39秒前
我是老大应助科研通管家采纳,获得10
39秒前
英姑应助科研通管家采纳,获得10
39秒前
高分求助中
LNG地下式貯槽指針(JGA Guideline-107)(LNG underground storage tank guidelines) 1000
Generalized Linear Mixed Models 第二版 1000
rhetoric, logic and argumentation: a guide to student writers 1000
QMS18Ed2 | process management. 2nd ed 1000
Asymptotically optimum binary codes with correction for losses of one or two adjacent bits 800
Preparation and Characterization of Five Amino-Modified Hyper-Crosslinked Polymers and Performance Evaluation for Aged Transformer Oil Reclamation 700
Operative Techniques in Pediatric Orthopaedic Surgery 510
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 免疫学 细胞生物学 电极
热门帖子
关注 科研通微信公众号,转发送积分 2925815
求助须知:如何正确求助?哪些是违规求助? 2573285
关于积分的说明 6949562
捐赠科研通 2226139
什么是DOI,文献DOI怎么找? 1183086
版权声明 589099
科研通“疑难数据库(出版商)”最低求助积分说明 578941